Bell F., Martin A., Blondeau C., et al.Combined DTP and HIB vaccines for primary immunization. Archives of Disease in Childhood. 1996; 75: 298-303.
WHO Expert Committee on Biological Standatization (WHO technical reports series 927/ 2003.
WHO Expert Committee on Biological Standatization (WHO technical reports series 1004 / 2017.
Guideline on clinical evaluation of new vaccines (EMEA/CHMP/VWP/164653/2005).
Guideline on requirements for vaccine antigen master file (VAMF) certification (EMEA/CPMP/4548/03/Final Rev 1/ 2005.
Verdier F., Patriarca C., Descotes J. Autoantibodies in conventional toxicity testing. Toxicology. 1997; 119: 51-8.
Note for guidance on pharmaceutical and biological aspects of combined vaccines (EMEA/ CPMP/BWP/477/97).
Findlow H., Borrow R. Interactions of conjugate vaccines and co-administered vaccines. Human Vaccines & Immunotherapeutics. 2016; 12: 226-30.
Guide for the Care and Use of Laboratory Animals. National Academy Press. Washington, D.C. 8-th ed. 1996.
European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS Council of Europe №123/1986).
Приказ Министерства здравоохранения РФ от 21.03.2014 г. № 125н «Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям»
Guidance for industry for the evaluation of combination vaccines for preventable diseases: production, testing and clinical studies (FDA/ 1997).
Note for guidance on pharmaceutical and biological aspects of combined vaccines (EMEA/ CPMP/BWP/477/97).
Guidelines on the nonclinical evalution of vaccine adjuvants and adjuvanted vaccines (WHO/ 17122013/ 2013).
Guideline on adjuvants in vaccines for human use (EMEA/CHMP/VEG/134716/2004).
Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products (EMEA/CPMP/SWP/28367/rev 1 2017)/
Приказ Министерства здравоохранения РФ от 1 апреля 2016 г. № 200н «Об утверждении правил надлежащей клинической практики»
ICH E6(R1) - Integrated addendum to: Guideline for good clinical practice (2016).
Guideline on the Choice of the Non-Inferiority Margin (EMEA/CPMP/EWP/2158/99).
Points to Consider on Switching between Superiority and Non-Inferiority (Committee for Proprietary Medicinal Products (CPMP). Br. J. Clin. Pharmacol. 2001; 52(3): 223-8.
Statistical Principles for Clinical Trial (EMEA/ICH/EWP/363/96).